BDBM286014 (E/Z)-(+/-)-N-{2-[5-Chloro-2-(1H-1,2,3,4-tetrazol-1-yl)phenyl]ethyl}-2,10-dioxo-1,2,3,4,7,8,9,10-octahydro-1,9-benzodiazacyclododecine-8-carboxamide::US10081623, Example 27

SMILES Clc1ccc(c(CCNC(=O)C2CC=CCCC(=O)Nc3ccccc3C(=O)N2)c1)-n1cnnn1

InChI Key InChIKey=UDJKQCZYNZIIJX-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 286014   

TargetCoagulation factor XI(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286014(US10081623, Example 27 | (E/Z)-(+/-)-N-{2-[5-Chlor...)
Affinity DataKi:  39.1nMpH: 7.4Assay Description:The effectiveness of compounds of the present invention as inhibitors of the coagulation Factors XIa, VIIa, IXa, Xa, XIIa, plasma kallikrein or throm...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2019
Entry Details
US Patent